These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 15062190)

  • 1. Recent developments in the pathophysiology of cholestasis.
    Hutchins GF; Gollan JL
    Clin Liver Dis; 2004 Feb; 8(1):1-26, v. PubMed ID: 15062190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New molecular insights into the mechanisms of cholestasis.
    Wagner M; Zollner G; Trauner M
    J Hepatol; 2009 Sep; 51(3):565-80. PubMed ID: 19595470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Regulation of hepatobiliary transporters in cholestatic liver disease].
    Geier A; Gartung C; Matern S
    Med Klin (Munich); 2004 Jan; 99(1):7-17. PubMed ID: 14716480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations.
    Zollner G; Marschall HU; Wagner M; Trauner M
    Mol Pharm; 2006; 3(3):231-51. PubMed ID: 16749856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice.
    Wagner M; Halilbasic E; Marschall HU; Zollner G; Fickert P; Langner C; Zatloukal K; Denk H; Trauner M
    Hepatology; 2005 Aug; 42(2):420-30. PubMed ID: 15986414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic disorders and molecular mechanisms in cholestatic liver disease--a clinical approach.
    Trauner M; Fickert P; Zollner G
    Semin Gastrointest Dis; 2001 Apr; 12(2):66-88. PubMed ID: 11352122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular transport in acquired cholestasis: new insights into functional, regulatory and therapeutic aspects.
    Roma MG; Crocenzi FA; Sánchez Pozzi EA
    Clin Sci (Lond); 2008 May; 114(9):567-88. PubMed ID: 18377365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The enterohepatic nuclear receptors are major regulators of the enterohepatic circulation of bile salts.
    Houten SM; Auwerx J
    Ann Med; 2004; 36(7):482-91. PubMed ID: 15513299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine-independent repression of rodent Ntcp in obstructive cholestasis.
    Geier A; Zollner G; Dietrich CG; Wagner M; Fickert P; Denk H; van Rooijen N; Matern S; Gartung C; Trauner M
    Hepatology; 2005 Mar; 41(3):470-7. PubMed ID: 15723437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of nuclear receptors and hepatocyte-enriched transcription factors for Ntcp repression in biliary obstruction in mouse liver.
    Zollner G; Wagner M; Fickert P; Geier A; Fuchsbichler A; Silbert D; Gumhold J; Zatloukal K; Kaser A; Tilg H; Denk H; Trauner M
    Am J Physiol Gastrointest Liver Physiol; 2005 Nov; 289(5):G798-805. PubMed ID: 16002565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTalpha-OSTbeta in cholestasis in humans and rodents.
    Boyer JL; Trauner M; Mennone A; Soroka CJ; Cai SY; Moustafa T; Zollner G; Lee JY; Ballatori N
    Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1124-30. PubMed ID: 16423920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From blood to bile: recent advances in hepatobiliary transport.
    Arrese M; Accatino L
    Ann Hepatol; 2002; 1(2):64-71. PubMed ID: 15115970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatobiliary transporters and drug-induced cholestasis.
    Pauli-Magnus C; Meier PJ
    Hepatology; 2006 Oct; 44(4):778-87. PubMed ID: 17006912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of disease: mechanisms and clinical implications of cholestasis in sepsis.
    Geier A; Fickert P; Trauner M
    Nat Clin Pract Gastroenterol Hepatol; 2006 Oct; 3(10):574-85. PubMed ID: 17008927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of nuclear receptors for bile acid metabolism, bile secretion, cholestasis, and gallstone disease.
    Claudel T; Zollner G; Wagner M; Trauner M
    Biochim Biophys Acta; 2011 Aug; 1812(8):867-78. PubMed ID: 21194565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear receptors: mediators and modifiers of inflammation-induced cholestasis.
    Mulder J; Karpen SJ; Tietge UJ; Kuipers F
    Front Biosci (Landmark Ed); 2009 Jan; 14(7):2599-630. PubMed ID: 19273222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in growth hormone receptor abundance regulate growth hormone signaling in murine obstructive cholestasis.
    Held MA; Cosme-Blanco W; Difedele LM; Bonkowski EL; Menon RK; Denson LA
    Am J Physiol Gastrointest Liver Physiol; 2005 May; 288(5):G986-93. PubMed ID: 15604202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of cholestasis.
    Zollner G; Trauner M
    Clin Liver Dis; 2008 Feb; 12(1):1-26, vii. PubMed ID: 18242495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of transporters by nuclear hormone receptors: implications during inflammation.
    Teng S; Piquette-Miller M
    Mol Pharm; 2008; 5(1):67-76. PubMed ID: 18072749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The delta opioid receptor 1 is expressed by proliferating bile ductules in rats with cholestasis: implications for the study of liver regeneration and malignant transformation of biliary epithelium.
    Nicoll J; Axiotis CA; Bergasa NV
    Med Hypotheses; 2005; 65(6):1099-105. PubMed ID: 16125331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.